Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Summer 2023 ACIP Update: RSV Prevention and Updated Recommendations on Other Vaccines
2023
· University of Colorado,
· Children's National Hospital,
· University of South Florida,
· University of Alabama at Birmingham,
· University of Cincinnati,
· Cincinnati Children's Hospital Medical Center
This article describes updates from the Advisory Committee on Immunization Practices (ACIP) about vaccines for children. It highlights new recommendations for using nirsevimab, a monoclonal …
Ask aRCie
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower RespiratoryTract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United Sta
This article discusses the use of Pfizer's RSV vaccine for pregnant women to protect infants from RSV-related lung disease. The CDC recommends giving the vaccine …
Universal Infant Immunisation Against Respiratory Syncytial Virus and European Inequalities: The Pandemics Lesson Has Not Been Learnt
2023
· Hôpital Antoine-Béclère AP-HP,
· Université Paris-Saclay,
· American College of Emergency Physicians,
· Hospital General Universitario Gregorio Marañón,
· St. Marien Children's Hospital,
· University Medical Centre Utrecht,
· Respiratory Syncytial Virus NETwork (ReSViNET) Foundation,
· University Hospital of Padova
This comment discusses the challenges of implementing universal infant immunization against respiratory syncytial virus (RSV) in Europe. RSV is a major cause of illness in …
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023
This article describes the use of nirsevimab, a new drug approved in 2023, to prevent severe respiratory syncytial virus (RSV) disease in infants and young …
What Is the New RSV Immunization for Infants?
This short video discusses a new FDA-approved product that prevents serious RSV disease in children. It's not a typical vaccine but a monoclonal antibody given …
RSV Prevention Update: ACIP/AAP Recommendations for Nirsevimab in Infants and RSV Vaccine in Pregnancy
These presentation slides provide information for physicians about recommendations for nirsevimab for prevention of serious lower respiratory tract infection from respiratory syncytial virus (RSV) in …
Efficacy of Nirsevimab Against Respiratory Syncytial Virus Lower Respiratory Tract Infections in Preterm and Term Infants, and Pharmacokinetic Extrapolation to Infants With Congenital Heart Disease and Chronic Lung Disease: A Pooled Analysis of Randomised Controlled Trials
2023
· Children's Hospital Colorado,
· University of the Witwatersrand,
· Northwestern University,
· Dr. Georgi Stranski University Hospital,
· Quironsalud Madrid University Hospital,
· State University of New York - Upstate Medical University
This article describes a study on the effectiveness of nirsevimab in preventing respiratory syncytial virus (RSV) infections in infants. It focuses on both preterm and …
Review and Update of Active and Passive Immunization Against Respiratory Syncytial Virus
This article reviews ways to protect against respiratory syncytial virus (RSV). It describes both active and passive immunization methods. Active immunization involves vaccines that help …
Nirsevimab Brings Breakthrough in the Prevention of Respiratory Syncytial Virus Infection in Infants - Importance of Design
2023
· Capital Medical University
This editorial reviews the clinical studies on nirsevimab and discusses what roles the design has played in the studies. Nirsevimab is a monoclonal antibody that …
Primary Care Perspectives: Episode 154 - Nirsevimab (Beyfortus)
This podcast discusses a new preventative medicine called nirsevimab (Beyfortus), which is now available to protect infants and high-risk toddlers from respiratory syncytial virus (RSV). …